In a publication in Clinical Proteomics led by Drs. Brent Richards and Guillaume Butler-Laporte (McGill University), CITF funded researcher Dr. Daniel Kaufmann (Université de Montréal) and Dr. Vincent Mooser (McGill University, former director of the Biobanque québécoise de la COVID-19 (BQC19)) determined that severe COVID-19 is associated with significant changes in 69 immune-related proteins.